Archives of Virology

, Volume 154, Issue 6, pp 939–944 | Cite as

Field assessment of an H5N1 inactivated vaccine in chickens and ducks in Lao PDR

  • David A. Boltz
  • Bounlom Douangngeun
  • Settha Sinthasak
  • Phouvong Phommachanh
  • Phetlamphone Midouangchanh
  • David Walker
  • Rachael Keating
  • Alexey M. Khalenkov
  • Mahesh Kumar
  • Robert G. Webster
Original Article

Abstract

Despite the extensive use of poultry vaccines to control the spread of H5N1 influenza in poultry, H5N1 outbreaks continue to occur in domestic birds. Our objective was to determine the duration of the neutralizing antibody response under field conditions after vaccination with a laboratory-tested inactivated reverse genetics-derived H5N3 vaccine. H5N3 hemagglutination inhibition (HI) and virus neutralization (VN) antibodies were observed 40 weeks after vaccination of chickens with two doses and vaccination of ducks with one dose. Cross-clade antibodies to an H5N1 virus (A/chicken/Laos/A0464/07) antigenically distinct from the vaccine strain were detected in ducks after a single vaccination and were sustained for 28 weeks (for 40 weeks when a boost vaccination was given). Our results indicate that this inactivated H5N3 vaccine can produce long-lasting antibodies to homologous and heterologous viruses under field conditions.

Notes

Acknowledgments

This work was supported by contract HHSN266200700005C from the National Institute of Allergy and Infectious Diseases and by the American Lebanese Syrian Associated Charities (ALSAC). Sincere thanks to Dr. Bounkhouang Khambounheuang, Director General of the Lao PDR Department of Livestock and Fisheries, for his support, and to the Vaccine Production Centre of that Department for the use of its laboratory and animal husbandry facilities. We thank Scott Krauss for technical assistance and Sharon Naron for editorial assistance.

References

  1. 1.
    Aymard-Henry M, Coleman MT, Dowdle WR, Laver WG, Schild GC, Webster RG (1973) Influenzavirus neuraminidase and neuraminidase-inhibition test procedures. Bull World Health Organ 48:199–202PubMedGoogle Scholar
  2. 2.
    Beato MS, Toffan A, De Nardi R, Cristalli A, Terregino C, Cattoli G, Capua I (2007) A conventional, inactivated oil emulsion vaccine suppresses shedding and prevents viral meat colonisation in commercial (Pekin) ducks challenged with HPAI H5N1. Vaccine 25:4064–4072PubMedGoogle Scholar
  3. 3.
    Bertelsen MF, Klausen J, Holm E, Grondahl C, Jorgensen PH (2007) Serological response to vaccination against avian influenza in zoo-birds using an inactivated H5N9 vaccine. Vaccine 25:4345–4349PubMedCrossRefGoogle Scholar
  4. 4.
    Bublot M, Le Gros FX, Nieddu D, Pritchard N, Mickle TR, Swayne DE (2007) Efficacy of two H5N9-inactivated vaccines against challenge with a recent H5N1 highly pathogenic avian influenza isolate from a chicken in Thailand. Avian Dis 51:332–337PubMedCrossRefGoogle Scholar
  5. 5.
    Ellis TM, Bousfield RB, Bissett LA, Dyrting KC, Luk GS, Tsim ST, Sturm-Ramirez K, Webster RG, Guan Y, Malik Peiris JS (2004) Investigation of outbreaks of highly pathogenic H5N1 avian influenza in waterfowl and wild birds in Hong Kong in late 2002. Avian Pathol 33:492–505PubMedCrossRefGoogle Scholar
  6. 6.
    Ellis TM, Leung CY, Chow MK, Bissett LA, Wong W, Guan Y, Malik Peiris JS (2004) Vaccination of chickens against H5N1 avian influenza in the face of an outbreak interrupts virus transmission. Avian Pathol 33:405–412PubMedCrossRefGoogle Scholar
  7. 7.
    Hulse-Post DJ, Sturm-Ramirez KM, Humberd J, Seiler P, Govorkova EA, Krauss S, Scholtissek C, Puthavathana P, Buranathai C, Nguyen TD, Long HT, Naipospos TS, Chen H, Ellis TM, Guan Y, Peiris JS, Webster RG (2005) Role of domestic ducks in the propagation and biological evolution of highly pathogenic H5N1 influenza viruses in Asia. Proc Natl Acad Sci USA 102:10682–10687PubMedCrossRefGoogle Scholar
  8. 8.
    Isoda N, Sakoda Y, Kishida N, Soda K, Sakabe S, Sakamoto R, Imamura T, Sakaguchi M, Sasaki T, Kokumai N, Ohgitani T, Saijo K, Sawata A, Hagiwara J, Lin Z, Kida H (2008) Potency of an inactivated avian influenza vaccine prepared from a non-pathogenic H5N1 reassortant virus generated between isolates from migratory ducks in Asia. Arch Virol 153:1685–1692PubMedCrossRefGoogle Scholar
  9. 9.
    Keawcharoen J, van Riel D, van Amerongen G, Bestebroer T, Beyer WE, van Lavieren R, Osterhaus AD, Fouchier RA, Kuiken T (2008) Wild ducks as long-distance vectors of highly pathogenic avian influenza virus (H5N1). Emerg Infect Dis 14:600–607PubMedCrossRefGoogle Scholar
  10. 10.
    Kida H, Ito T, Yasuda J, Shimizu Y, Itakura C, Shortridge KF, Kawaoka Y, Webster RG (1994) Potential for transmission of avian influenza viruses to pigs. J Gen Virol 75(Pt 9):2183–2188PubMedCrossRefGoogle Scholar
  11. 11.
    Kim JK, Seiler P, Forrest HL, Khalenkov AM, Franks J, Kumar M, Karesh WB, Gilbert M, Sodnomdarjaa R, Douangngeun B, Govorkova EA, Webster RG (2008) Pathogenicity and vaccine efficacy of different clades of Asian H5N1 avian influenza A viruses in domestic ducks. J Virol 82:11374–11382PubMedCrossRefGoogle Scholar
  12. 12.
    Kumar M, Chu HJ, Rodenberg J, Krauss S, Webster RG (2007) Association of serologic and protective responses of avian influenza vaccines in chickens. Avian Dis 51:481–483PubMedCrossRefGoogle Scholar
  13. 13.
    Lee CW, Senne DA, Suarez DL (2004) Effect of vaccine use in the evolution of Mexican lineage H5N2 avian influenza virus. J Virol 78:8372–8381PubMedCrossRefGoogle Scholar
  14. 14.
    Lin YJ, Deng MC, Wu SH, Chen YL, Cheng HC, Chang CY, Lee MS, Chien MS, Huang CC (2008) Baculovirus-derived hemagglutinin vaccine protects chickens from lethal homologous virus H5N1 challenge. J Vet Med Sci 70:1147–1152PubMedCrossRefGoogle Scholar
  15. 15.
    Liu M, Wood JM, Ellis T, Krauss S, Seiler P, Johnson C, Hoffmann E, Humberd J, Hulse D, Zhang Y, Webster RG, Perez DR (2003) Preparation of a standardized, efficacious agricultural H5N3 vaccine by reverse genetics. Virology 314:580–590PubMedCrossRefGoogle Scholar
  16. 16.
    Middleton D, Bingham J, Selleck P, Lowther S, Gleeson L, Lehrbach P, Robinson S, Rodenberg J, Kumar M, Andrew M (2007) Efficacy of inactivated vaccines against H5N1 avian influenza infection in ducks. Virology 359:66–71PubMedCrossRefGoogle Scholar
  17. 17.
    Dung Nguyen T, Vinh Nguyen T, Vijaykrishna D, Webster R, Guan Y, Peiris J, Smith G (2008) Multiple sublineages of influenza A virus (H5N1), Vietnam, 2005–2007. Emerg Infect Dis 14:632–636PubMedCrossRefGoogle Scholar
  18. 18.
    Palmer DF, Coleman MT, Dowdle WR, Schild GC (1975) Advanced laboratory techniques for influenza diagnosis. Immunology. US Deparment of Health, Education and Welfare, AtlantaGoogle Scholar
  19. 19.
    Romer-Oberdorfer A, Veits J, Helferich D, Mettenleiter TC (2008) Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus. Vaccine 26:2307–2313PubMedCrossRefGoogle Scholar
  20. 20.
    Savill NJ, St Rose SG, Keeling MJ, Woolhouse ME (2006) Silent spread of H5N1 in vaccinated poultry. Nature 442:757PubMedCrossRefGoogle Scholar
  21. 21.
    Sims LD (2007) Lessons learned from Asian H5N1 outbreak control. Avian Dis 51:174–181PubMedCrossRefGoogle Scholar
  22. 22.
    Steensels M, Van Borm S, Lambrecht B, De Vriese J, Le Gros FX, Bublot M, van den Berg T (2007) Efficacy of an inactivated and a fowlpox-vectored vaccine in Muscovy ducks against an Asian H5N1 highly pathogenic avian influenza viral challenge. Avian Dis 51:325–331PubMedCrossRefGoogle Scholar
  23. 23.
    Steensels M, Bublot M, Van Borm S, De Vriese J, Lambrecht B, Richard-Mazet A, Chanavat-Bizzini S, Duboeuf M, Le Gros FX, van den Berg T (2009) Prime-boost vaccination with a fowlpox vector and an inactivated avian influenza vaccine is highly immunogenic in Pekin ducks challenged with Asian H5N1 HPAI. Vaccine 27:646–654PubMedCrossRefGoogle Scholar
  24. 24.
    Sturm-Ramirez KM, Hulse-Post DJ, Govorkova EA, Humberd J, Seiler P, Puthavathana P, Buranathai C, Nguyen TD, Chaisingh A, Long HT, Naipospos TS, Chen H, Ellis TM, Guan Y, Peiris JS, Webster RG (2005) Are ducks contributing to the endemicity of highly pathogenic H5N1 influenza virus in Asia? J Virol 79:11269–11279PubMedCrossRefGoogle Scholar
  25. 25.
    Swayne DE, Garcia M, Beck JR, Kinney N, Suarez DL (2000) Protection against diverse highly pathogenic H5 avian influenza viruses in chickens immunized with a recombinant fowlpox vaccine containing an H5 avian influenza hemagglutinin gene insert. Vaccine 18:1088–1095PubMedCrossRefGoogle Scholar
  26. 26.
    Swayne DE, Perdue ML, Beck JR, Garcia M, Suarez DL (2000) Vaccines protect chickens against H5 highly pathogenic avian influenza in the face of genetic changes in field viruses over multiple years. Vet Microbiol 74:165–172PubMedCrossRefGoogle Scholar
  27. 27.
    Swayne DE, Lee CW, Spackman E (2006) Inactivated North American and European H5N2 avian influenza virus vaccines protect chickens from Asian H5N1 high pathogenicity avian influenza virus. Avian Pathol 35:141–146PubMedCrossRefGoogle Scholar
  28. 28.
    Tian G, Zhang S, Li Y, Bu Z, Liu P, Zhou J, Li C, Shi J, Yu K, Chen H (2005) Protective efficacy in chickens, geese and ducks of an H5N1-inactivated vaccine developed by reverse genetics. Virology 341:153–162PubMedCrossRefGoogle Scholar
  29. 29.
    van der Goot JA, van Boven M, de Jong MC, Koch G (2007) Effect of vaccination on transmission of HPAI H5N1: the effect of a single vaccination dose on transmission of highly pathogenic avian influenza H5N1 in Peking ducks. Avian Dis 51:323–324PubMedCrossRefGoogle Scholar
  30. 30.
    van der Goot JA, van Boven M, Stegeman A, van de Water SG, de Jong MC, Koch G (2008) Transmission of highly pathogenic avian influenza H5N1 virus in Pekin ducks is significantly reduced by a genetically distant H5N2 vaccine. Virology 382:91–97PubMedCrossRefGoogle Scholar
  31. 31.
    Veits J, Romer-Oberdorfer A, Helferich D, Durban M, Suezer Y, Sutter G, Mettenleiter TC (2008) Protective efficacy of several vaccines against highly pathogenic H5N1 avian influenza virus under experimental conditions. Vaccine 26:1688–1696PubMedCrossRefGoogle Scholar
  32. 32.
    Villarreal CL (2006) Control and eradication strategies of avian influenza in Mexico. Dev Biol (Basel) 124:125–126Google Scholar
  33. 33.
    Webster RG, Webby RJ, Hoffmann E, Rodenberg J, Kumar M, Chu HJ, Seiler P, Krauss S, Songserm T (2006) The immunogenicity and efficacy against H5N1 challenge of reverse genetics-derived H5N3 influenza vaccine in ducks and chickens. Virology 351:303–311PubMedCrossRefGoogle Scholar
  34. 34.
    Wood JM, Kawaoka Y, Newberry LA, Bordwell E, Webster RG (1985) Standardization of inactivated H5N2 influenza vaccine and efficacy against lethal A/Chicken/Pennsylvania/1370/83 infection. Avian Dis 29:867–872PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • David A. Boltz
    • 1
  • Bounlom Douangngeun
    • 2
  • Settha Sinthasak
    • 2
  • Phouvong Phommachanh
    • 2
  • Phetlamphone Midouangchanh
    • 2
  • David Walker
    • 1
  • Rachael Keating
    • 1
  • Alexey M. Khalenkov
    • 1
  • Mahesh Kumar
    • 3
  • Robert G. Webster
    • 1
  1. 1.Department of Infectious Diseases, Division of VirologySt. Jude Children’s Research HospitalMemphisUSA
  2. 2.National Animal Health Centre, Department of Livestock and FisheriesMinistry of AgricultureVientianeLao PDR
  3. 3.Fort Dodge Animal Health (a Division of Wyeth)Fort DodgeUSA

Personalised recommendations